Campylobacter pylori and non-ulcer dyspepsia. 2. A prospective study in a Swedish population

Scand J Gastroenterol Suppl. 1989:167:44-8. doi: 10.3109/00365528909091310.

Abstract

In a consecutive prospective series of 186 Swedish persons with the diagnosis of non-ulcer dyspepsia 71.5% were found to have gastritis and/or bulbar duodenitis in endoscopic biopsies. Gastroduodenitis was associated with campylobacter pylori (CP) in 83.5% of the cases. The double therapeutic approach using an antibiotic and a preparation containing bismuth in an uncontrolled therapeutic pilot trial resulted in improvement of the histological picture, disappearance of CP and amelioration of symptoms. It is concluded that CP-infection plays a central role in the pathogenesis of gastroduodenitis associated NUD.

MeSH terms

  • Adult
  • Aluminum Hydroxide / therapeutic use
  • Anti-Ulcer Agents / therapeutic use
  • Bismuth / therapeutic use
  • Campylobacter / isolation & purification
  • Campylobacter Infections / drug therapy
  • Campylobacter Infections / epidemiology*
  • Drug Combinations / therapeutic use
  • Dyspepsia / drug therapy
  • Dyspepsia / epidemiology*
  • Dyspepsia / etiology
  • Erythromycin / therapeutic use
  • Female
  • Glycyrrhiza
  • Humans
  • Magnesium Hydroxide
  • Male
  • Plant Extracts / therapeutic use
  • Prevalence
  • Prospective Studies
  • Sodium Bicarbonate
  • Sweden / epidemiology

Substances

  • Anti-Ulcer Agents
  • Drug Combinations
  • Plant Extracts
  • aluminum hydroxide, bismuth subnitrate, deglycyrrhizinised liquorice, magnesium carbonate, sodium bicarbonate drug combination
  • Aluminum Hydroxide
  • Erythromycin
  • Sodium Bicarbonate
  • Magnesium Hydroxide
  • Bismuth